Animal Stem Cell Therapy Market is expected to surge around US$ 437.3 Mn by the end of 2032 at a CAGR of 5.2% | PMR

The animal stem cell therapy market is expected to see significant growth in 2022 as more veterinarians and pet owners turn to stem cell therapy as a treatment option for a variety of conditions in animals. Stem cell therapy involves the use of stem cells, which are cells that have the ability to develop into different types of cells, to repair or regenerate damaged tissues.

In animals, stem cell therapy is most commonly used to treat conditions such as osteoarthritis, muscle injuries, and skin wounds. It is also being explored as a potential treatment for a variety of other conditions, including heart disease and neurological disorders.

Animal Stem Cell Therapy Market Size (2021)- US$ 249.9 Mn
Projected Market Value (2032)-US$ 437.3 Mn
Global Market Growth Rate (2022-2032)-5.2% CAGR
Share of Top 5 Companies- 55.6%

Request For Free Sample Report of "Animal Stem Cell Therapy Market"@ https://www.persistencemarketresearch.com/samples/14941

In recent years, the demand for animal stem cell therapy has increased significantly, driven by the growing awareness of the benefits of stem cell therapy and the increasing prevalence of chronic diseases in animals. The market is expected to continue to grow in the coming years, with a projected CAGR of around 5.2% from 2022 to 2032.

Companies

Aratana Therapeutics, Inc.
VetStem, Inc.
Regeneus Ltd.
Magellan Stem Cells
PrimeGen Biotech, LLC
Vetbiologics (.U.S. Stem Cell, Inc.)
Boehringer Ingelheim (Global stem cell technology)
Cell Therapy Sciences
MediVet Biologics LLC (Ardent Animal Health)

 Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/14941

There are several key players in the animal stem cell therapy market, including Regeneus, Vet-Stem, BioMedVet, and VetCell Bioscience. These companies offer a variety of stem cell therapies for different species of animals, including dogs, cats, horses, and livestock.

The use of animal stem cell therapy is still in the early stages of development, and there is a need for further research to fully understand the potential of these therapies. However, the growing body of evidence supporting the effectiveness of stem cell therapy in animals is likely to drive further growth in the market in the coming years.

Competitive Landscape

The market for animal stem cell therapy is moderately fragmented with the presence of well-established players. The market is subject to high competition, and market players actively seek collaborative approaches for new product development to ensure increased product outreach.

Acquisitions and mergers within the industry further promote the market presence of manufacturers, thus propelling the overall industry.

In 2019, Medrego launched a new stem cell therapy product for the well-being of dogs. CaniCell is used for the treatment of osteoarthritis and other degenerative diseases in canines.
In 2019, Elanco Animal Health Incorporated acquired Aratana Therapeutics. This acquisition was completed to develop and commercialize innovative therapeutics for canines and felines.
In 2021, Boehringer Ingelheim partnered with PetMedix, a U.K.-based company involved in the antibody research & development of animal health.

 Request Customization @ https://www.persistencemarketresearch.com/request-customization/14941

Key Segments Covered in Animal Stem Cell Therapy Industry Research

Animal Stem Cell Therapy Market by Product Type:

Hemopoietic Stem Cells
Mesenchymal Stem Cells

Animal Stem Cell Therapy Market by Source:

Allogeneic Animal Stem Cell Therapy
Autologous Animal Stem Cell Therapy

Animal Stem Cell Therapy Market by Application:

Osteoarthritis
Soft Tissue Injuries
Traumatic Fractures
Tendonitis
Inflammatory Bowel Disease
Others

Animal Stem Cell Therapy Market by Species:

Canine
Feline
Equine

Animal Stem Cell Therapy Market by End User:

Veterinary Hospitals
Veterinary Clinics
Veterinary Research Institutes

For More Premium Insights, Check out the Link:

Endoscopic Spinal Surgery Market - https://www.prnewswire.com/news-releases/endoscopic-spinal-surgery-market-is-expected-to-exhibit-a-cagr-of-over-8-through-the-forecast-period-2021--2031-persistence-market-research-301335524.html

Animal Drug Compounding Market - https://www.prnewswire.com/news-releases/animal-drug-compounding-market-is-set-to-witness-healthy-growth-at-a-cagr-of-8-over-the-forecast-period-of-2021-2031-persistence-market-research-301307646.html

Rheumatoid Arthritis Treatment Market - https://www.prnewswire.com/news-releases/rheumatoid-arthritis-treatment-market-is-expected-to-exhibit-a-cagr-of-around-6-over-the-forecast-period-2021--2031---persistence-market-research-301293405.html

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.